Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists

Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC33398 O(6)-Benzylguanine Featured
O(6)-Benzylguanine is an MGMT inhibitor that prevents the repair of DNA damage induced by chemotherapeutics. It allows apoptosis and other mechanisms of cell death to occur.
More description
DC24081 Lyn-IN-1 (Synonyms: Bafetinib analog) Featured
Lyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor..
More description
DC10278 LGD-6972 Featured
LGD-6972 is a selective and orally active glucagon receptor antagonist. LGD-6972 has the potential for type 2 diabetes research.
More description
DC25092 Wortmannin Featured
A potent PI3K inhibitor with IC50 3 nM, does not inhibit PI4K activity.
More description
DC31763 Mianserin Featured
Mianserin is a psychoactive drug of the tetracyclic antidepressant (TeCA) therapeutic family. It is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA) and has antidepressant, anxiolytic (anti-anxiety), hypnotic (sedating), antiemetic (nausea and vomiting-attenuating), orexigenic (appetite-stimulating), and antihistamine effects.
More description
DC31926 Mianserin hydrochloride Featured
Mianserin hydrochloride is a tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
More description
DC28316 Prolyl Endopeptidase Inhibitor 1 Featured
Prolyl Endopeptidase Inhibitor 1 (Boc-Pro-prolinal) is a potent prolyl endopeptidase (PEP; PE) inhibitor, with a Ki value of 15 nM. Prolyl Endopeptidase Inhibitor 1 has anti-amnesic effect.
More description
DC28174 BNC210 Featured
BNC210 (H-Ile-Trp-OH; IW-2143) is a α7 nAChR negative allosteric modulator. BNC210 has potent activity in animal models of anxiety and depression.
More description
DC23919 CGP-42112 Featured
CGP-42112 (CGP42112A) is a highly potent, selective Angiotensin-II subtype 2 receptor(AT2 receptor) agonist with Ki of 0.24 nM.
More description
DC25093 Neuromedin N Featured
A neuropeptide derived from the same precursor polypeptide as neurotensin, and with similar but subtly distinct expression and effects..
More description
DC22894 SHU-9119 Featured
A potent melanocortin MC3 and MC4 receptor antagonist with IC50 of 0.23 nM and 0.06 nM, respectively.
More description
DC20205 Super-TDU Featured
Super-TDU is an inhibitory peptide targeting YAP-TEADs interaction.
More description
DC21487 PF-05190457 Featured
A potent, selective, and orally bioavailable ghrelin receptor (GHSR) inverse agonist with binding pKi of 8.36.
More description
DC7166 KN92 phosphate Featured
KN-92 is an inactive derivative of KN-93. KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase (Ki = 370 nM).
More description
DC9050 Melphalan Featured
Melphalan(Sarcolysin; L-PAM) is a chemotherapy drug belonging to the class of nitrogen mustard alkylating agents; attaches the alkyl group to the guanine base of DNA.
More description
DC11782 IDF-11774 Featured
IDF-11774 is a novel hypoxia-inducible factor α (HIFα)-1 inhibitor with an IC50 of 3.65 μM.
More description
DC7426 HS-173 Featured
HS-173 is a potent PI3Kα inhibitor with IC50 of 0.8 nM.
More description
DC7969 PS-1145 Featured
PS-1145 has been shown to be an IKK (IKB kinase) inhibitor.
More description
DC24098 Tipifarnib S enantiomer Featured
Tipifarnib S enantiomer is a potent and selective inhibitor of FTase (farnesyltransferase).
More description
DC22533 Eleclazine hydrochloride Featured
A novel, potent, and selective inhibitor of Late sodium current (late INa) for treatment of long QT-3 syndrome (LQT-3), hypertrophic cardiomyopathy (HCM), and ventricular tachycardia–ventricular fibrillation (VT–VF).
More description
DC21787 UU-T03 Featured
UU-T03 is the ethyl ester derivative of UU-T02, which is a potent, selective inhibitor of β-catenin/Tcf4 interaction with Ki of 1.36 uM; exhibits growth inhibition of SW480 cells with IC50 of 10.77 uM; downregulates the transcription of AXIN2, LGR5, cyclin D1, and c-Myc in dose-dependent manners in SW480 cells.
More description
DC10417 Acumapimod (BCT197) Featured
Acumapimod (BCT197) is an orally active p38 MAP kinase inhibitor, with an IC50 of less than 1 μM for p38α.
More description
DC9979 PRX-08066 Featured
PRX-08066 is a selective 5-hydroxytryptamine receptor 2B (5-HT2BR, IC50= 3.4 nM) antagonist that causes selective vasodilation of pulmonary arteries.
More description
DC9096 Tamoxifen Featured
Tamoxifen(ICI-46474) is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen.
More description
DC9717 amyloid P-IN-1(GSK3039294) Featured
GSK3039294 is a Serum amyloid P component inhibitor.
More description
DC7999 LDC1267 Featured
LDC1267 is a highly selective TAM(Tyro3, Axl and Mer) kinase inhibitor with IC50 of <5 nM/8 nM/29 nM for Tyro3,Axl and Mer respectively.
More description
DC12392 Gemcabene Featured
Gemcabene (PD-72953, PD72953) is a first-in-class lipid-lowering agent and activator of PARP.
More description
DC7203 MRS 2578 Featured
MRS2578 is a potent P2Y6 receptor antagonist with IC50 of 37 nM, exhibits insignificant activity at P2Y1, P2Y2, P2Y4,and P2Y11 receptors.
More description
DC7963 NSC-23766 free base Featured
NSC 23766 is a specific inhibitor of the binding and activation of RAC GTPase with IC50 of ~50 μM; does not inhibit the closely related targets, Cdc42 or RhoA.
More description
DC7763 NVP-AST487 Featured
AST 487 is a RET kinase inhibitor with IC50 of 880 nM, inhibits RET autophosphorylation and activation of downstream effectors, also inhibits Flt-3 with IC50 of 520 nM.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X